PetMed Express (PETS) Tops Q1 View
PetMed Express, Inc. (NASDAQ: PETS) reports Q1 EPS of $0.28, 1 cent better than the analyst estimate of $0.27. Revenues for the quarter were $68.4 million, versus the consensus of $65.28 million.
PetMed Express, Inc., doing business as 1-800-PetMeds, engages in the marketing and sale of prescription and non-prescription pet medications, and other health products for dogs, cats, and horses.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
